Home » Reports » Broker Ratings » Smith & Nephew plc 0.2% Potential Decrease Indicated by UBS

Smith & Nephew plc 0.2% Potential Decrease Indicated by UBS

Smith & Nephew plc with EPIC/TICKER (LON:SN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ today by analysts at UBS. Smith & Nephew plc are listed in the Health Care sector within UK Main Market. UBS have set their target price at 1830 GBX on its stock. This indicates the analyst believes there is a potential downside of -.2% from the opening price of 1833.5 GBX. Over the last 30 and 90 trading days the company share price has increased 104 points and increased 248.5 points respectively. The 52 week high for the stock is 1940 GBX while the 52 week low for the stock is 1242.5 GBX.

Smith & Nephew plc has a 50 day moving average of 1,748.48 GBX and a 200 Day Moving Average share price is recorded at 1,548.67. There are currently 874,536,338 shares in issue with the average daily volume traded being 2,357,376. Market capitalisation for LON:SN is £15,864,329,344 GBP.